Skip to main content
. 2020 Sep 10;12(4):390–398. doi: 10.1016/j.chmed.2020.02.006

Table 3.

Antibacterial activity and combined effects of TASA, MT and CIP alone or in combination.

Drug combinations Bacterial strains Individual MICsa Combination MICsa Combined FICIs Interaction
TASA(mg·mL−1)/CIP(μg·mL−1) S3 25/8 3.125/8 1.125 ADD or IND
ATCC35984 25/0.25 1.56/0.25 1.00625 ADD or IND



MT(mg·mL−1)/CIP(μg·mL−1) S3 25/8 3.125/8 1.125 ADD or IND
ATCC35984 25/0.25 1.56/0.25 1.00625 ADD or IND
a

Results represented means of three independent experiments. SYN: synergy; ADD or IND: additive or indifference. ANT: antagonism.